Founded
Address
Sanderling Ventures
400 South El Camino Real
Suite 1200
San Mateo, CA 94402
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30602
Corporate information
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Sanderling Venture Partners IV LP | ||||
| Sanderling V Biomedical LP | ||||
| Sanderling IV Biomedical LP |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 57| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Asteres Inc | Commercialized a system to store and deliver finished prescriptions to consumers in retail pharmacy. | N/A | |||
|
|
BioSpace Inc | Most comprehensive life sciences-related information resource company. | N/A | |||
|
|
CalciMedica | Discoverer and developer of novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. | N/A | |||
|
|
Cardionet Inc | N/A | ||||
|
|
Chimerix Inc | Series F | ||||
|
|
Chimerix Inc | Series E | ||||
|
|
Chimerix Inc | Series D | ||||
|
|
Chimerix Inc | Series C | ||||
|
|
Chimerix Inc | N/A | ||||
|
|
CoMentis Inc | N/A | ||||
|
|
Dendreon Corp | A biotechnology company focused on targeting cancer | N/A | |||
|
|
Digirad Corp | Solid-state gamma cameras company for nuclear cardiology and general nuclear medicine applications. | N/A | |||
|
|
DynaTherm Medical Inc | Series B | ||||
|
|
Dynavax Technologies Corp | N/A | ||||
|
|
Endocyte Inc | Folate-based cancer and autoimmune disease therapies | Series C | |||
|
|
Gemin X Biotechnologies Inc | Biotechnology company developing novel cancer treatments based on the regulation of apoptosis. | N/A | |||
|
|
Gemin X Pharmaceuticals Inc | Series C | ||||
|
|
InfraReDx Inc | Medical device company focused on developing and delivering products and technologies for improved clinical decision-making. | Series D | |||
|
|
InterMune Inc | Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. | N/A | |||
|
|
ISTA Pharmaceuticals Inc | Specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. | N/A | |||
|
|
Kadmus Pharmaceuticals Inc | Biopharmaceutical company developing therapeutics for the treatment of pain, obesity, and other unmet medical needs. | N/A | |||
|
|
Naviscan Inc (Naviscan PET Systems Inc) | Series C | ||||
|
|
Novocell Inc | Stem cell engineering company. | N/A | |||
|
|
NovoStent Corp | N/A | ||||
|
|
Pacira Pharmaceuticals Inc | Acute care specialty pharmaceutical company. | N/A |